Comparison of the acute-phase response after laparoscopic versus open aortobifemoral bypass surgery: a substudy of a randomized controlled trial

Autor: Krog AH, Sahba M, Pettersen EM, Sandven I, Thorsby PM, Jørgensen JJ, Sundhagen JO, Kazmi SS

Publikováno v: Vascular Health and Risk Management, Vol Volume 12, Pp 371-378 (2016)

Anne H Krog,1,2 Mehdi Sahba,3 Erik M Pettersen,4 Irene Sandven,5 Per M Thorsby,1,6 Jørgen J Jørgensen,1,2 Jon O Sundhagen,2 Syed SS Kazmi2 1Institute of Clinical Medicine, University of Oslo, 2Department of Vascular Surgery, Division of Cardiovascu

Externí odkaz: https://doaj.org/article/39db523d9d7646a6956a6aae71d4330e

The short cosyntropin test revisited - new normal reference range using LCMSMS

Autor: Øksnes M, Løvås K, Ueland Gå, Sagen J, P. Methlie, Husebye Es, Kellmann R, Ræder M, Thordarson Hb, Dahlqvist P, Dahl, Mellgren G, Thorsby Pm

Publikováno v: Yearbook of Paediatric Endocrinology.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::459bbc6d496b7318c1646c8dc8d9cc7a
https://doi.org/10.1530/ey.15.8.9

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Peroxisome proliferator-activated receptor-[gamma]2 Pro12Ala polymorphism, cod liver oil and risk of type 1 diabetes.

Autor: Stene LC, Thorsby PM, Berg JP, Rønningen KS, Joner G

Publikováno v: Pediatric Diabetes; Feb2008, Vol. 9 Issue 1, p40-45, 6p

Elevated interleukin 8 and matrix metalloproteinase 9 levels are associated with myocardial pathology in users of anabolic-androgenic steroids.

Autor: Gregersen I; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway., Scarth ME; Anabolic Androgenic Steroid Research Group, Section of Clinical Addiction Research, Division of Mental Health and Addiction, Oslo University Hospital, Sognsvannsveien 21, 0372 Oslo, Norway., Abdullah R; Anabolic Androgenic Steroid Research Group, Section of Clinical Addiction Research, Division of Mental Health and Addiction, Oslo University Hospital, Sognsvannsveien 21, 0372 Oslo, Norway.; ProCardio Center for Research-Based Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway., Thorsby PM; Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway.; Hormone Laboratory, Department of Medical Biochemistry, Oslo University Hospital, Aker, Trondheimsveien 235,0586 Oslo, Norway.; Biochemical Endocrinology and Metabolism Research Group, Oslo University Hospital, Aker, Trondheimsveien 235, 0586 Oslo, Norway., Hauger LE; Anabolic Androgenic Steroid Research Group, Section of Clinical Addiction Research, Division of Mental Health and Addiction, Oslo University Hospital, Sognsvannsveien 21, 0372 Oslo, Norway.; National Centre for Epilepsy, Section of Clinical Psychology and Neuropsychology, Oslo University Hospital, Henriksens vei, Sandvika, Norway., Haugaa KH; ProCardio Center for Research-Based Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway., Sagen EL; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway., Michelsen AE; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway., Ueland T; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway.; Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway, Universitetsvegen 57, 9019 Tromsø, Norway., Edvardsen T; ProCardio Center for Research-Based Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway., Aukrust P; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway., Almaas VM; ProCardio Center for Research-Based Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway., Bjørnebekk AK; Anabolic Androgenic Steroid Research Group, Section of Clinical Addiction Research, Division of Mental Health and Addiction, Oslo University Hospital, Sognsvannsveien 21, 0372 Oslo, Norway., Halvorsen B; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Sognsvannsveien 20, 0372 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Kirkeveien 166, 0450, Oslo, Norway.

Publikováno v: European journal of preventive cardiology [Eur J Prev Cardiol] 2024 Sep 06; Vol. 31 (12), pp. 1469-1476.